These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9303183)

  • 21. Synthetic 2'-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity.
    Wan MS; Fell PL; Akhtar S
    Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):309-17. PubMed ID: 9743468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substitution of non-catalytic stem and loop regions of hammerhead ribozyme with DNA counterparts only increases KM without sacrificing the catalytic step (kcat): a way to improve substrate-specificity.
    Shimayama T; Sawata S; Komiyama M; Takagi Y; Tanaka Y; Wada A; Sugimoto N; Rossi JJ; Nishikawa F; Nishikawa S
    Nucleic Acids Symp Ser; 1992; (27):17-8. PubMed ID: 1283905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical nature of a specific uridine O2-carbonyl for cleavage by the hammerhead ribozyme.
    Bevers S; Ha SB; McLaughlin LW
    Biochemistry; 1999 Jun; 38(24):7710-8. PubMed ID: 10387010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
    Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
    Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of hammerhead ribozymes for optimum cleavage of interleukin 6 mRNA.
    Hendrix C; Anné J; Joris B; Van Aerschot A; Herdewijn P
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):655-61. PubMed ID: 8670082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of phosphorothioate and 2-amino groups in hammerhead ribozymes on cleavage rates and Mg2+ binding.
    Koizumi M; Ohtsuka E
    Biochemistry; 1991 May; 30(21):5145-50. PubMed ID: 2036380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High activity and stability of hammerhead ribozymes containing 2'-modified pyrimidine nucleosides and phosphorothioates.
    Heidenreich O; Benseler F; Fahrenholz A; Eckstein F
    J Biol Chem; 1994 Jan; 269(3):2131-8. PubMed ID: 8294467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LNA nucleotides improve cleavage efficiency of singular and binary hammerhead ribozymes.
    Christiansen JK; Lobedanz S; Arar K; Wengel J; Vester B
    Bioorg Med Chem; 2007 Sep; 15(18):6135-43. PubMed ID: 17624789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activities of tRNA-embedded dimeric minizymes.
    Kuwabara T; Warashina M; Nakayama A; Ohkawa J; Taira K
    Nucleic Acids Symp Ser; 1997; (37):307-8. PubMed ID: 9586122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase.
    Sioud M; Jespersen L
    J Mol Biol; 1996 Apr; 257(4):775-89. PubMed ID: 8636981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and application of asymmetric hammerhead ribozymes.
    Hammann C; Tabler M
    Methods; 1999 Jul; 18(3):273-80. PubMed ID: 10454985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evolution suggests multiple origins for the hammerhead ribozyme.
    Salehi-Ashtiani K; Szostak JW
    Nature; 2001 Nov; 414(6859):82-4. PubMed ID: 11689947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural flexibility and the thermodynamics of helix exchange constrain attenuation and allosteric activation of hammerhead ribozyme TRAPs.
    Saksmerprome V; Burke DH
    Biochemistry; 2003 Dec; 42(47):13879-86. PubMed ID: 14636055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization in vitro and in vivo of hammerhead ribozymes directed against murine tumor necrosis factoralpha.
    MacKay SL; Tannahill CL; Auffenberg T; Ksontini R; Copeland EM; Moldawer LL
    Biochem Biophys Res Commun; 1999 Jul; 260(2):390-7. PubMed ID: 10403780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-Deazaadenosine: synthesis and activity of base-modified hammerhead ribozymes.
    Seela F; Debelak H; Usman N; Burgin A; Beigelman L
    Nucleic Acids Res; 1998 Feb; 26(4):1010-8. PubMed ID: 9461461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient hammerhead ribozyme and antisense RNA targeting in a slow ribosome Escherichia coli mutant.
    Chen H; Ferbeyre G; Cedergren R
    Nat Biotechnol; 1997 May; 15(5):432-5. PubMed ID: 9131620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural similarities between hammerhead ribozymes and the spliceosomal RNAs could be responsible for lack of ribozyme cleavage in yeast.
    Castanotto D; Li H; Chow W; Rossi JJ; Deshler JO
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):1-13. PubMed ID: 9512091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-II ribonucleic acid in vitro and in prostate cancer cells.
    Xu ZD; Oey L; Mohan S; Kawachi MH; Lee NS; Rossi JJ; Fujita-Yamaguchi Y
    Endocrinology; 1999 May; 140(5):2134-44. PubMed ID: 10218964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance.
    Beigelman L; McSwiggen JA; Draper KG; Gonzalez C; Jensen K; Karpeisky AM; Modak AS; Matulic-Adamic J; DiRenzo AB; Haeberli P
    J Biol Chem; 1995 Oct; 270(43):25702-8. PubMed ID: 7592749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.